Big pharma still makes billions after patents lapse

Doctors in the US are wasting hundreds of millions of dollars a year prescribing expensive branded medicines even when cheaper generic alternatives are available, according to an FT analysis. David Crow and Sujeet Indap discuss the findings.

Hosted on Acast. See acast.com/privacy for more information.

More from FT News in Focus

  1. 17:59Introducing: The Rachman ReviewMar 25, 2020
  2. 10:56Republican $1tn plan, Paul Tucker on damage limitsMar 20, 2020
  3. 07:56Rana Foroohar on the trillion dollar fightback, Biden sweepMar 18, 2020
  4. 09:04World on lockdown, markets melt, hospitals sufferMar 17, 2020
  5. 08:18Introducing the FT News Briefing: Fed cuts to zero, airport pinch, hand sanitiser saleMar 16, 2020
  6. 16:04Persecution of China's Uighur Muslims exposedMar 11, 2020
  7. 14:40Will coronavirus cause a global recession?Mar 09, 2020
  8. 13:52Secrets of the South PoleMar 04, 2020
  9. 13:52Is India becoming a Big Brother state?Mar 02, 2020
  10. 17:14Is Trump abusing his power over the judiciary?Feb 26, 2020